J P M O R G A N North America Equity Research 26 June 2026 U.S. SMid Biotech ACAD / CYTK / XENE / BHVN – Weekly Rx Trends Below, we highlight the latest trends in IQVIA U.S. prescription data for key commercial products in our coverage universe and relevant competitors. The data below for Nuplazid, Camzyos and select epilepsy drugs are updated through June 19, 2026, reflecting a shortened week due to the Juneteenth holiday. | Company | Drug | Approved Indication | | --- | --- | --- | | ACAD | Nuplazid | Par ...